Benign paroxysmal positional vertigo differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 29: | Line 29: | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan=" | | colspan="5" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard''' | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
| colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | | colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms''' | ||
! | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acute onset | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acute onset | ||
| Line 44: | Line 44: | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nystagmus | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nystagmus | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hearing problems | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hearing problems | ||
|- | |- | ||
| colspan=" | | colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |'''Peripheral''' | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Benign paroxysmal positional vertigo|BPPV]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Benign paroxysmal positional vertigo|BPPV]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |+/− | |||
| style="background: #F5F5F5; padding: 5px;" |− | |||
| style="background: #F5F5F5; padding: 5px;" |+ Dix-Hallpike maneuver | |||
| style="background: #F5F5F5; padding: 5px;" |− | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Dix-Hallpike maneuver | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular neuritis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular neuritis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 81: | Line 70: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |HSV oticus | | style="background: #DCDCDC; padding: 5px; text-align: center;" |HSV oticus | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 95: | Line 81: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Meniere disease | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Meniere disease | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 109: | Line 92: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 123: | Line 103: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Perilymphatic fistula | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Perilymphatic fistula | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 138: | Line 115: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Semicircular canal | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Semicircular canal | ||
dehiscence syndrome | dehiscence syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 152: | Line 126: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular paroxysma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular paroxysma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 166: | Line 137: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cogan syndrome | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cogan syndrome | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 180: | Line 148: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular schwannoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular schwannoma | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 194: | Line 159: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Otitis media | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Otitis media | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 208: | Line 170: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 222: | Line 181: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Recurrent vestibulopathy | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Recurrent vestibulopathy | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 235: | Line 191: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! colspan=" | ! colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Central | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular migrain | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vestibular migrain | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 253: | Line 206: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 266: | Line 216: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple sclerosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple sclerosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 280: | Line 227: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain tumors | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain tumors | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 294: | Line 238: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 308: | Line 249: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain stem ischemia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain stem ischemia | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 323: | Line 261: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Chiari malformation | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Chiari malformation | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 337: | Line 272: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Parkinson | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Parkinson | ||
| style="background: #F5F5F5; padding: 5px;" |− | | style="background: #F5F5F5; padding: 5px;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Revision as of 14:07, 10 April 2019
For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Differentiating [Disease name] from other Diseases
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
OR
As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
| Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||
|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Physical examination | ||||||||
| Lab Findings | Imaging | ||||||||
| Acute onset | Recurrency | Nystagmus | Hearing problems | ||||||
| Peripheral | |||||||||
| BPPV | + | + | +/− | − | + Dix-Hallpike maneuver | − | Dix-Hallpike maneuver | ||
| Vestibular neuritis | |||||||||
| HSV oticus | |||||||||
| Meniere disease | |||||||||
| Labyrinthine concussion | |||||||||
| Perilymphatic fistula | |||||||||
| Semicircular canal
dehiscence syndrome |
|||||||||
| Vestibular paroxysma | |||||||||
| Cogan syndrome | |||||||||
| Vestibular schwannoma | |||||||||
| Otitis media | |||||||||
| Aminoglycoside toxicity | |||||||||
| Recurrent vestibulopathy | + | ||||||||
| Central | |||||||||
| Vestibular migrain | + | ||||||||
| Epileptic vertigo | + | ||||||||
| Multiple sclerosis | |||||||||
| Brain tumors | |||||||||
| Crebellar infarction/hemorrhage | + | ||||||||
| Brain stem ischemia | + | ||||||||
| Chiari malformation | − | ||||||||
| Parkinson | − | ||||||||